证券代码： 000985 证券简称：大庆华科 公司将厘清各治理主体职责和边界，形成权责法定、权责透 明、协调运转、有效制衡的治理机制，保障各治理主体各司其职、 各负其责，促进公司的规范运作和健康发展。推进落实董事会中 长期发展决策权、经理层成员选聘权、经理层成员业绩考核权、 经理层成员薪酬管理权、职工工资分配管理权、重大财务事项管 理权等六项职权，有效促进董事会治理效率和行权履职能力大 幅，充分发挥董事会"定战略、作决策、防风险"的职能作用。 大庆华科股份有限公司投资者关系活动记录表 | 投资者关系活动 | □特定对象调研 分析师会议 □ | | --- | --- | | 类别 | 业绩说明会 □ 媒体采访 √ | | | □ 新闻发布会 □ 路演活动 | | | □ 现场参观 | | | □ 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 投资者网上提问 | | 人员姓名 | | | 时间 | 2023 年 5 月 15 日 (周一) 下午 14:00~16:30 | | 地点 | 公司通过全景网"投资者关系互动平台"（https://ir.p5w.net） | | | 采用网络远程的方式召 ...

证券代码：000985 证券简称：大庆华科 公告编号：2023020 大庆华科股份有限公司 关于参加"2023 年投资者网上集体接待日 暨业绩说明会活动"的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，大庆华科股份有限公司（以 下简称"公司"）将参加由黑龙江证监局、黑龙江省上市公司协会与 深圳市全景网络有限公司联合举办的"2023 年黑龙江辖区上市公司 投资者集体接待日暨业绩说明会活动"，现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演" 网站（http://rs.p5w.net）；或关注微信公众号（名称：全景财经）； 或下载全景路演 APP,参与本次互动交流。活动时间为 2023 年 5 月 15 日（周一）14:00-16:30。届时公司财务总监武云峰女士，独立董事 王涌先生，董事会秘书孟凡礼先生将在线就公司 2022 年度业绩、公 司治理、发展战略、经营状况、融资计划、股权激励和可持续发展等 投资者关心的问题，与投资者进行沟通与交流。 为充分尊重投资者、提升交流的针对性，现就公司本次 ...

证券代码：000985 证券简称：大庆华科 公告编号：2023020 大庆华科股份有限公司 关于参加"2023 年投资者网上集体接待日 暨业绩说明会活动"的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，大庆华科股份有限公司（以 下简称"公司"）将参加由黑龙江证监局、黑龙江省上市公司协会与 深圳市全景网络有限公司联合举办的"2023 年黑龙江辖区上市公司 投资者集体接待日暨业绩说明会活动"，现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演" 网站（http://rs.p5w.net）；或关注微信公众号（名称：全景财经）； 或下载全景路演 APP,参与本次互动交流。活动时间为 2023 年 5 月 15 日（周一）14:00-16:30。届时公司财务总监武云峰女士，独立董事 王涌先生，董事会秘书孟凡礼先生将在线就公司 2022 年度业绩、公 司治理、发展战略、经营状况、融资计划、股权激励和可持续发展等 投资者关心的问题，与投资者进行沟通与交流。 为充分尊重投资者、提升交流的针对性，现就公司本次 ...

Financial Performance - The company's operating revenue for 2022 was ¥2,609,036,852.21, representing a 25.83% increase compared to ¥2,073,428,194.93 in 2021[6]. - The net profit attributable to shareholders for 2022 was ¥15,408,919.20, a 19.98% increase from ¥12,842,754.34 in 2021[6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥11,958,066.78, up 25.25% from ¥9,547,556.30 in 2021[6]. - The basic and diluted earnings per share for 2022 were both ¥0.119, reflecting a 20.20% increase from ¥0.099 in 2021[6]. - The total operating revenue for 2022 was ¥2,609,036,852.21, representing a year-on-year increase of 27.11% from ¥2,073,428,194.93 in 2021[52]. - The gross profit margin for the chemical industry was 3.94%, a decrease of 1.92% compared to the previous year[53]. - The total operating cost increased by 28.40% to ¥2,506,206,934.63 from ¥1,951,879,305.00 in 2021[55]. - The company reported a significant decline in cash flow from operating activities, with a net outflow of ¥15,197,855.75 in 2022 compared to a net inflow of ¥63,163,053.33 in 2021, a decrease of 124.06%[6]. Shareholder Information - The company plans to distribute a cash dividend of 0.48 RMB per 10 shares to all shareholders, based on a total of 129,639,500 shares[6]. - The company reported a net profit of 15.41 million yuan for the period, with a total distributable profit of 110.35 million yuan[97]. - A cash dividend of 0.48 yuan per 10 shares was proposed, amounting to a total cash dividend of 6.22 million yuan, which represents 100% of the profit distribution[97]. - The company did not make any adjustments to its cash dividend policy during the reporting period[97]. Business Operations - The company has not changed its business scope during the reporting period, which includes the production and sales of fine chemical products and health food[17]. - The company has undergone several changes in its business scope since its establishment, with the latest change approved in 2015[17]. - The company is listed on the Shenzhen Stock Exchange under the stock code 000985[14]. - The company’s registered address is located in Daqing High-tech Industrial Development Zone, Heilongjiang Province[14]. - The company has designated China Securities Journal and Giant Tide Information Network as its official information disclosure media[5]. Market Outlook - The company anticipates a recovery in the petrochemical industry in 2023, with improved operating rates and profitability expected due to easing cost pressures[27]. - The company expects an overall increase in C5 resin consumption from 2023 to 2025, particularly in road marking paint and adhesives, driven by economic recovery[32]. - The company is focusing on high-value-added product development to enhance overall competitiveness and risk resistance in response to macroeconomic fluctuations[40]. Research and Development - The company has a stable R&D team of 68 members, with 34 senior engineers and 26 engineers[46]. - R&D expenses surged by 112.11% to ¥16,087,350.78 in 2022 from ¥7,584,466.29 in 2021, driven by increased R&D compensation[60]. - Total R&D investment rose by 29.08% to ¥92,377,895.31 in 2022 from ¥71,567,800.00 in 2021, representing 3.54% of operating revenue[61]. Environmental Compliance - The company is classified as a key pollutant discharge unit and adheres to relevant environmental protection laws and standards[106]. - The company invested a total of 6.0608 million yuan in environmental governance and protection during the reporting period[110]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[112]. - The company has established emergency response plans for environmental incidents, which have been reviewed by experts and filed with relevant authorities[108]. Corporate Governance - The company maintains a complete and independent governance structure, ensuring compliance with relevant laws and regulations[71]. - The company has established an independent financial department and accounting system, ensuring financial independence from its controlling shareholder[73]. - The company has a total of six independent directors, enhancing corporate governance and oversight[85]. - The company has established a remuneration and assessment committee responsible for evaluating senior management performance and determining compensation[86]. Financial Position - The total assets at the end of 2022 were ¥706,073,765.92, a slight increase of 0.09% from ¥705,436,187.12 at the end of 2021[6]. - The net assets attributable to shareholders at the end of 2022 were ¥603,170,642.04, up 1.84% from ¥592,292,056.90 at the end of 2021[6]. - The total liabilities decreased to ¥102,903,123.88 in 2022 from ¥113,144,130.22 in 2021, a reduction of 9.3%[159]. Related Party Transactions - The company reported a total of 262,889.82 million CNY in related party transactions, accounting for 71.79% of the approved transaction amount of 284,221 million CNY[123]. - The company engaged in raw material procurement from China National Petroleum Corporation Daqing Petrochemical Branch, with transaction value of 241,909.19 million CNY, representing 97.36% of similar transactions[123]. Management Changes - The company reported a significant management change, with the resignation of key personnel including the former General Manager Han Yuehui and several other executives due to work-related reasons[77]. - The current Chairman, Shi Tiequan, has a background in finance and has held various senior positions within the China National Petroleum Corporation[78]. - The new General Manager, Gong Xiangying, has been appointed and has extensive experience in the petrochemical industry[79]. Compliance and Risk Management - The company emphasizes compliance and risk prevention, establishing a robust internal control system[51]. - The internal control audit report received a standard unqualified opinion, confirming the effectiveness of the internal control system[103]. - The company has not encountered any major issues in the management and control of its subsidiaries during the reporting period[99].

Financial Performance - The company's operating revenue for Q1 2023 was ¥629,173,594.69, an increase of 2.02% compared to ¥616,709,642.53 in the same period last year[3] - Net profit attributable to shareholders decreased by 82.47% to ¥2,273,226.83 from ¥12,964,510.88 year-on-year[3] - The net profit after deducting non-recurring gains and losses fell by 86.83% to ¥1,623,668.20 from ¥12,329,026.83 in the previous year[3] - Basic and diluted earnings per share both decreased by 82.00% to ¥0.018 from ¥0.100 year-on-year[3] - The operating profit for Q1 2023 was CNY 2,621,587.62, down 82.8% from CNY 15,227,874.59 in Q1 2022[15] - The total comprehensive income for Q1 2023 was CNY 2,273,226.83, significantly lower than CNY 12,964,510.88 in Q1 2022[15] Cash Flow and Liquidity - Cash flow from operating activities improved significantly, reaching ¥23,254,404.49, compared to a negative cash flow of ¥5,052,681.00 in the same period last year, representing a 560.24% increase[3] - The cash and cash equivalents at the end of Q1 2023 amounted to CNY 248,525,268.02, compared to CNY 228,687,496.92 at the beginning of the year, indicating a growth of 8.3%[11] - The cash and cash equivalents at the end of Q1 2023 amounted to CNY 248,525,268.02, slightly down from CNY 250,194,369.72 at the end of Q1 2022[18] - The net cash flow from investing activities was CNY -3,416,633.39, compared to CNY -2,905,940.56 in Q1 2022[18] Assets and Liabilities - Total assets at the end of the reporting period were ¥723,240,713.05, an increase of 2.43% from ¥706,073,765.92 at the end of the previous year[3] - Total assets as of the end of Q1 2023 were CNY 723,240,713.05, an increase from CNY 706,073,765.92 at the beginning of the year[14] - Total liabilities increased to CNY 117,990,522.50 from CNY 102,903,123.88, representing a rise of 14.7%[13] Shareholder Information - The total number of common shareholders at the end of the reporting period was 10,031[6] - The largest shareholder, China Petroleum Daqing Petrochemical Co., Ltd., holds 55.03% of the shares[6] - Shareholders' equity attributable to shareholders increased slightly by 0.34% to ¥605,250,190.55 from ¥603,170,642.04 at the end of the previous year[3] Operational Metrics - Total operating costs for Q1 2023 were CNY 622,783,990.80, up from CNY 601,545,404.03, reflecting a year-over-year increase of 3.7%[14] - Gross profit margin for Q1 2023 was approximately 1.6%, down from the previous year's margin[14] - Inventory at the end of Q1 2023 was CNY 140,404,795.13, up from CNY 126,991,745.34, reflecting an increase of 10.5%[12] - The company reported a decrease in accounts payable from CNY 26,368,633.96 to CNY 22,952,222.23, a reduction of 13.5%[13] Government Support and R&D - The company received government subsidies amounting to ¥711,392.82, with a net impact of ¥649,558.63 after tax considerations[5] - The company plans to continue focusing on research and development, with R&D expenses for Q1 2023 amounting to CNY 3,427,151.44, slightly down from CNY 3,677,702.08 in the previous year[14] Other Information - The company did not report any significant new product developments or market expansions during this quarter[15] - The company reported an asset impairment loss of CNY -4,571,967.06, compared to CNY -762,649.72 in the previous year[15] - Sales revenue from goods and services received cash of CNY 716,067,889.76, an increase from CNY 701,519,167.69 in the same period last year[17]

Financial Performance - The company's operating revenue for Q3 2022 was ¥712,125,992.19, representing a 31.92% increase year-over-year[3] - The net profit attributable to shareholders for the same period was ¥13,199,910.04, up 54.21% compared to the previous year[3] - The net profit after deducting non-recurring gains and losses reached ¥12,585,991.97, an increase of 81.55% year-over-year[3] - The basic earnings per share for Q3 2022 was ¥0.101, a 53.03% increase compared to the same period last year[3] - Total operating revenue for Q3 2022 reached CNY 2,042,605,504.47, an increase of 32.7% compared to CNY 1,538,693,303.11 in the same period last year[18] - Operating profit for the period was CNY 26,118,187.32, up 59.3% from CNY 16,380,921.66 in the previous year[18] - Net profit attributable to shareholders was CNY 22,226,240.07, representing a 70.5% increase from CNY 13,047,610.87 in the prior year[18] - Earnings per share (EPS) for the period was CNY 0.171, compared to CNY 0.101 in the same quarter last year, reflecting a 69.3% increase[19] Assets and Liabilities - The total assets at the end of the reporting period were ¥785,660,880.66, reflecting a 2.15% increase from the end of the previous year[3] - As of September 30, 2022, the total assets of Daqing Huake Co., Ltd. amounted to RMB 785,660,880.66, an increase from RMB 705,436,187.12 at the beginning of the year[15] - The total liabilities increased to CNY 169,539,955.96, up from CNY 113,144,130.22, indicating a growth of 49.8%[16] - Current liabilities amounted to CNY 121,629,532.81, significantly higher than CNY 63,082,053.24, marking a 93.1% increase[16] - The total equity attributable to shareholders increased to CNY 616,120,924.70, compared to CNY 592,292,056.90, reflecting a growth of 4.0%[16] Cash Flow - Cash flow from operating activities for the year-to-date was ¥98,502,496.05, down 26.17% compared to the previous year[3] - Cash inflow from operating activities totaled CNY 2,336,645,656.4, a rise of 31.4% from CNY 1,776,851,518.50 in the previous year[20] - The net cash flow from operating activities was 98,502,496.05, a decrease of 26.1% compared to 133,418,346.74 in the previous period[21] - The total cash outflow from operating activities amounted to 2,238,143,160.3, up from 1,643,433,171.76, indicating a significant increase in operational expenses[21] - The net cash flow from investing activities was -3,756,030.56, an improvement from -7,129,309.37 in the previous period, reflecting reduced investment losses[21] - The net cash flow from financing activities was -5,963,417.00, consistent with the previous period, indicating stable financing costs[21] - The ending balance of cash and cash equivalents was 346,936,039.77, slightly up from 340,206,551.85, indicating a stable liquidity position[21] Research and Development - Research and development expenses increased by 89.57% to ¥11,343,155.78 due to a rise in personnel involved in R&D[8] - Research and development expenses rose to CNY 11,343,155.78, up 89.5% from CNY 5,983,615.14 in the previous year[18] Shareholder Information - The company’s major shareholder, China National Petroleum Corporation, holds a 55.03% stake in the company[10] - The top shareholder, China Petroleum Daqing Petrochemical Co., Ltd., holds 71,339,700 shares, representing a significant portion of the company's equity[11] - The company has a total of 10,980,900 shares held by Daqing High-tech State-owned Assets Operation Co., Ltd., indicating strong institutional support[11] Other Information - The company has not disclosed any new product developments or technological advancements in the current report[12] - Future outlook and performance guidance were not explicitly detailed in the available documents[12] - The report for the third quarter was unaudited, which may affect the reliability of the financial data presented[22]

Financial Performance - The company's operating revenue for the first half of 2022 was approximately ¥1.33 billion, representing a 33.20% increase compared to ¥998.88 million in the same period last year[18]. - The net profit attributable to shareholders for the first half of 2022 was approximately ¥9.03 million, a significant increase of 101.12% from ¥4.49 million in the previous year[18]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was approximately ¥7.31 million, up 102.59% from ¥3.61 million year-on-year[18]. - The basic earnings per share for the first half of 2022 was ¥0.070, doubling from ¥0.035 in the same period last year[18]. - The company reported a net cash flow from operating activities of approximately ¥37.47 million, which is a 5.92% increase compared to ¥35.37 million in the previous year[18]. Assets and Liabilities - The company's total assets at the end of the reporting period were approximately ¥746.70 million, reflecting a 5.85% increase from ¥705.44 million at the end of the previous year[18]. - The net assets attributable to shareholders at the end of the reporting period were approximately ¥599.88 million, a slight increase of 1.28% from ¥592.29 million at the end of the previous year[18]. - Total liabilities reached RMB 146,816,702.24, an increase of 29.8% from RMB 113,144,130.22 at the beginning of the year[95]. - Non-current liabilities decreased slightly to RMB 48,626,879.70 from RMB 50,062,076.98, a decline of 2.9%[95]. Operational Focus - The company continues to focus on the production and sales of petrochemical products, with no significant changes in its main business operations[24]. - The company produces a variety of products including C5 and C9 petroleum resins, refined acetonitrile, and polypropylene, which are widely used in various industrial fields[24]. - The company is leveraging regional advantages to develop high-value-added products, promoting sustainable high-quality growth[31]. Research and Development - Research and development investment rose by 68.01% to ¥7,262,500.70, reflecting an increase in personnel and organizational adjustments[33]. - The company holds 13 national patents, including 8 invention patents, all of which have been industrialized, with core technologies for major products being proprietary[29]. - The company has a stable core management team and a professional R&D team of 68 members, enhancing its technological capabilities[28]. Sales and Market Presence - The sales network is well-established, with products exported to over 20 countries and regions, including Europe, Southeast Asia, and North America[31]. - Domestic sales accounted for 98.35% of total revenue, while international sales contributed 1.65%, showing a decline in foreign sales[35]. Environmental Compliance - The company has implemented measures to ensure compliance with environmental protection standards, including regular audits and pollution control facilities[55]. - The company has reported no significant violations of pollution discharge standards during the reporting period[56]. - The company received environmental impact assessment approval for the polypropylene unit bottleneck elimination project, which began trial production in November 2021 and is currently undergoing environmental completion acceptance[57]. - The company has implemented an environmental self-monitoring plan, with all monitoring data reported within permissible limits according to national standards[60]. Financial Management - The company has a deposit balance of 14,646 million CNY with Kunlun Bank, which is below the approved limit of 16,000 million CNY[74]. - The interest income from Kunlun Bank amounted to 143.99 million CNY, representing 62.10% of the total interest income from related parties[71]. - The company reported no significant related party transactions during the reporting period[72]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,439[84]. - China National Petroleum Daqing Oil Refining and Chemical Co., Ltd. holds 55.03% of the shares, totaling 71,339,700 shares[84]. - The largest shareholder, China National Petroleum Daqing Oil Refining and Chemical Co., Ltd., has no pledged or frozen shares[84]. Risk Factors - The company is facing risks from macroeconomic fluctuations and stricter energy policies, which may impact operational performance[42]. - The company plans to enhance its energy efficiency and reduce costs through technical upgrades and process improvements in response to rising energy prices[43]. Corporate Governance - The company has established a comprehensive internal control system to protect the interests of shareholders, particularly minority shareholders, and ensures timely and accurate information disclosure[62]. - The company has not engaged in any significant asset or equity sales during the reporting period[41]. - The company has not experienced any major safety incidents or environmental pollution events during the reporting period, with 14 safety inspections conducted by authorities[65].

Financial Performance - The company's operating revenue for 2021 was ¥2,073,428,194.93, an increase of 17.60% compared to ¥1,763,044,476.17 in 2020[17]. - The net profit attributable to shareholders for 2021 was ¥12,842,754.34, reflecting a growth of 5.88% from ¥12,129,725.55 in 2020[17]. - The net profit attributable to shareholders after deducting non-recurring gains and losses surged by 211.20% to ¥9,547,556.30 from ¥3,068,025.86 in 2020[17]. - The company's total assets at the end of 2021 amounted to ¥705,436,187.12, a 1.55% increase from ¥694,655,529.43 at the end of 2020[17]. - The weighted average return on net assets for 2021 was 2.19%, up from 2.08% in 2020[17]. - The company reported a net cash flow from operating activities of ¥63,163,053.33, a slight decrease of 1.21% compared to ¥63,938,916.62 in 2020[17]. - The total operating revenue for 2021 was ¥2,073,428,194.93, representing a 17.60% increase from ¥1,763,044,476.17 in 2020[56]. - The gross profit margin for the chemical industry was 5.86%, with operating costs increasing by 19.54% year-over-year to ¥1,951,879,305.00[56]. - The total cost of sales for the year was 1,955,000,000.00 CNY, with a gross margin of approximately 5.55%[67]. - The company achieved operating revenue of 2.073 billion yuan and a net profit of 12.84 million yuan in 2021[53]. Shareholder Information - The company plans to distribute a cash dividend of 0.46 RMB per 10 shares to all shareholders, based on a total of 129,639,500 shares[4]. - The total distributable profit for shareholders was CNY 102.4454 million, after accounting for a net profit of CNY 12.8428 million and retained earnings from the previous year[106]. - The cash dividend accounted for 100% of the total profit distribution, adhering to the policy that at least 80% of profits should be distributed as cash dividends during the mature phase of the company[106]. - The company did not make any adjustments or changes to its cash dividend policy during the reporting period[106]. Business Operations - The company has not changed its business scope during the reporting period, which includes the production and sales of chemical products and health food[15]. - The company has undergone several changes in its major business operations since its establishment, including the addition of import and export business in 2001[15]. - The company produces a range of products including C9 and C5 resins, refined acetonitrile, and polypropylene, widely used in various industrial applications[42]. - The company has a production capacity of 14,000 tons/year for dark C9 resin and 6,000 tons/year for hot polymerized C9 resin, with stable product quality and target customers[32]. - The company’s main product categories included polypropylene and its modified products, which generated ¥760,916,295.09, accounting for 36.70% of total revenue, with a 20.40% year-over-year increase[56]. Market Outlook - The company anticipates a stable growth in the petrochemical industry in 2022, driven by energy transformation and demand growth in the new energy sector[25]. - The demand for C5 petroleum resin, a key product of the company, is expected to maintain a growth trend due to its wide applications in various industries[29]. - The company is expanding its market presence, targeting a 25% increase in market share in the next fiscal year[79]. - New product launches are expected to contribute an additional 300 million RMB in revenue in 2022[82]. Research and Development - The company has a stable core management team and a professional R&D team of 68 members, including 34 senior engineers[51]. - Research and development expenses for 2021 were CNY 7,584,466.29, slightly down from CNY 8,550,467.12 in 2020, a decrease of 11.3%[172]. - The company is in the trial production phase for several new products, including C5/C9 copolymer resin, aimed at enhancing product variety and profitability[64]. - Research and development investments increased by 30%, totaling 150 million RMB in 2021[80]. Risk Management - The company faces risks from macroeconomic fluctuations, energy policies, and international oil price volatility, which could impact operational performance[34][39]. - To mitigate risks, the company is focusing on high-value product development and optimizing production processes to enhance competitiveness[41]. - The company’s risk management capabilities were enhanced through the establishment of a comprehensive internal control system, effectively mitigating operational risks[55]. Environmental and Social Responsibility - The company maintained a zero incident rate for environmental pollution throughout the year, achieving 100% compliance in various safety and health metrics[55]. - The company reported a year-on-year decrease in CO2 emissions by 657.89 tons due to enhanced energy-saving measures and optimized production processes[117]. - The company has actively engaged in social responsibility initiatives, balancing economic and social benefits[119]. - The company invested 3.69 million yuan in safety production measures, including monitoring and health checks for employees[121]. Governance and Compliance - The company maintains a complete and independent governance structure, ensuring compliance with relevant laws and regulations[76]. - The financial statements are audited by Dahua Certified Public Accountants[16]. - The audit opinion for the financial statements is a standard unqualified opinion, indicating fair representation of the company's financial status as of December 31, 2021[150]. - The company has established a comprehensive salary management system, aligning compensation with industry standards and company performance[100]. Employee Information - The total number of employees at the end of the reporting period is 573, with 386 in production, 115 in technical roles, and 18 in sales[99]. - The total salary expense for employees is CNY 9,928.33 million, accounting for 4.82% of total costs, with R&D personnel salaries totaling CNY 740.86 million, representing 7.46% of total salary expenses[102]. - A total of 94 internal training sessions were completed, training 4,126 employees, while 51 external training sessions trained 190 employees, enhancing skills and responsibility[102].

大庆华科股份有限公司 2022 年第一季度报告全文 证券代码：000985 证券简称：大庆华科 公告编号：2022017 大庆华科股份有限公司 2022 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准 确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法 律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声 明：保证季度报告中财务信息的真实、准确、完整。 3.第一季度报告是否经过审计 √ 否 一、主要财务数据 (一)主要会计数据和财务指标 公司不存在其他符合非经常性损益定义的损益项目的具体情况。 公司不存在将《公开发行证券的公司信息披露解释性公告第 1 号——非经 常性损益》中列举的非经常性损益项目界定为经常性损益的项目的情形。 二、股东信息 (一)普通股股东总数和表决权恢复的优先股股东数量及前十名股东持股情 况表 公司无需追溯调整或重述以前年度会计数据 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | ...

Financial Performance - The company's operating revenue for Q1 2022 was ¥616,709,642.53, representing a 36.22% increase compared to ¥452,727,892.35 in the same period last year[3] - Net profit attributable to shareholders was ¥12,964,510.88, a significant increase of 659.11% from a loss of ¥2,318,782.60 in the previous year[3] - The net profit after deducting non-recurring gains and losses was ¥12,329,026.83, up 506.88% from a loss of ¥3,030,159.26 in the same period last year[3] - The basic earnings per share increased to ¥0.10 from a loss of ¥0.02, marking a 600.00% improvement[3] - Net profit for the quarter was ¥12,964,510.88, a turnaround from a net loss of ¥2,318,782.60 in the same period last year[15] Assets and Liabilities - The total assets at the end of the reporting period were ¥732,788,207.52, a 3.88% increase from ¥705,436,187.12 at the end of the previous year[3] - The equity attributable to shareholders increased by 2.62% to ¥607,812,084.96 from ¥592,292,056.90 at the end of the previous year[3] - Current assets totaled ¥367,545,795.43, up from ¥330,182,684.08, indicating an increase of 11.3%[12] - Inventory levels rose significantly to ¥109,247,418.59 from ¥66,482,080.58, representing a 64.3% increase[12] - The total liabilities increased to ¥124,976,122.56 from ¥113,144,130.22, reflecting a growth of 10.5%[13] Cash Flow - The net cash flow from operating activities was negative at -¥5,052,681.00, a decline of 123.19% compared to ¥21,787,016.61 in the same period last year[3] - Cash inflow from sales of goods and services reached 701,519,167.69, compared to 522,070,848.87 in the prior period, reflecting a growth of approximately 34.4%[18] - Total cash outflow from operating activities was 709,353,122.47, up from 504,068,953.58, representing an increase of about 40.7%[19] - The cash flow from investment activities was -2,905,940.56, an improvement from -3,037,034.82 in the previous period[19] - The net increase in cash and cash equivalents was -7,958,621.56, contrasting with an increase of 18,749,981.79 in the prior period[19] Operating Costs - The company reported a significant increase in operating costs, which rose by 34.15% to ¥573,268,363.05 due to higher raw material prices compared to the previous year[6] - Operating costs amounted to ¥601,545,404.03, up from ¥455,649,510.26, reflecting a rise of 32.0% year-over-year[14] - Cash paid for purchasing goods and services was 672,458,075.55, an increase from 473,587,076.40, showing a rise of approximately 42.0%[18] Research and Development - Research and development expenses increased to ¥3,677,702.08 from ¥2,330,889.93, showing a growth of 57.8% year-over-year[15] Shareholder Information - The top shareholder, China Petroleum Daqing Petrochemical Co., Ltd., holds 55.03% of the shares, totaling 71,339,700 shares[6] Government Subsidies - The company received government subsidies amounting to ¥723,137.15 during the reporting period[5] Taxation - The company paid 6,438,476.12 in taxes, significantly higher than 1,165,562.51 in the previous period, marking an increase of about 450.0%[19]